Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121434042 | 12143404 | 2 | F | 20160223 | 20160818 | 20160304 | 20160825 | EXP | CA-AMGEN-CANSP2016023548 | AMGEN | 56.00 | YR | A | F | Y | 0.00000 | 20160825 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121434042 | 12143404 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | U | 103795 | UNKNOWN FORMULATION | ||||||||
| 121434042 | 12143404 | 2 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Subcutaneous | 17.5 MG, UNK | 0 | 17.5 | MG | ||||||||
| 121434042 | 12143404 | 3 | SS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 1 G, CYCLICAL | 0 | 1 | G | ||||||||
| 121434042 | 12143404 | 4 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 121434042 | 12143404 | 5 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | 300 MG, QD | 0 | 300 | MG | TABLET | QD | ||||||
| 121434042 | 12143404 | 6 | SS | RISEDRONATE | RISEDRONATE SODIUM | 1 | Unknown | 35 MG, QWK | 0 | 35 | MG | TABLET | /wk | ||||||
| 121434042 | 12143404 | 7 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | 20 MG, QD | 0 | 20 | MG | TABLET | QD | ||||||
| 121434042 | 12143404 | 8 | SS | HUMIRA | ADALIMUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 121434042 | 12143404 | 9 | SS | REMICADE | INFLIXIMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 121434042 | 12143404 | 10 | C | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | 300 MG, ONCE A DAY | 0 | 300 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121434042 | 12143404 | 1 | Product used for unknown indication |
| 121434042 | 12143404 | 2 | Rheumatoid arthritis |
| 121434042 | 12143404 | 3 | Rheumatoid arthritis |
| 121434042 | 12143404 | 4 | Product used for unknown indication |
| 121434042 | 12143404 | 5 | Rheumatoid arthritis |
| 121434042 | 12143404 | 6 | Product used for unknown indication |
| 121434042 | 12143404 | 7 | Rheumatoid arthritis |
| 121434042 | 12143404 | 8 | Rheumatoid arthritis |
| 121434042 | 12143404 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121434042 | 12143404 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121434042 | 12143404 | Drug ineffective | |
| 121434042 | 12143404 | Infection | |
| 121434042 | 12143404 | Nausea | |
| 121434042 | 12143404 | Nodule | |
| 121434042 | 12143404 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121434042 | 12143404 | 1 | 2016 | 0 | ||
| 121434042 | 12143404 | 2 | 20150331 | 0 | ||
| 121434042 | 12143404 | 3 | 20160222 | 0 | ||
| 121434042 | 12143404 | 7 | 20160222 | 0 | ||
| 121434042 | 12143404 | 10 | 20160222 | 0 |